Mohali: An unpaved, badly damaged stretch of road in Phase 7 turned into a major traffic hazard after three two-wheeler ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a biopharmaceutical company dedicated to the discovery, development, manufacturing, ...
Hemab Therapeutics is building a hemostasis ladder, targeting ultra-rare to mass-market bleeding disorders, with a robust ...
Eli Lilly's eloralintide plus low‑dose tirzepatide cut weight up to 23.3% and A1C by 2.9% in a 48‑week Phase 2, beating ...
Eli Lilly (LLY) and Viking Therapeutics (VKTX) delivered back-to-back clinical wins in the same week — one pushing the ...
Nice to meet you, I'm Miumi.I'm part of a family of five—my husband and our three children—and this year marks exactly 10 ...
cUHDRS showed 80% slowing of disease progression compared to the updated external control (nominal p=0.005). Treated patients ...
The Oklahoma Supreme Court publicly reprimanded Tulsa County District Judge Sharon Holmes following an investigation into ...
From September 19 to 25, we covered a total of 7 items: 3 in oncology and 4 in neurology. There were 3 FDA approvals (gene ...
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient has been enrolled in COMPASSION-37 (AK104-311), ...
In-depth analysis, news, and expert commentary on cybersecurity, AI, and enterprise technology. Featuring the TechSpective ...
Ayal Aizer, MD, MHS, discusses patients for whom single-fraction SRS may remain reasonable after brain metastasis resection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results